Results 161 to 170 of about 25,224 (259)

Visit‐to‐visit systolic blood pressure variability, blood pressure treatment intensity, and cognitive decline

open access: yesAlzheimer's &Dementia, Volume 22, Issue 8, August 2026.
Abstract INTRODUCTION Visit‐to‐visit blood pressure variability (BPV) may be associated with cognitive decline beyond mean blood pressure (BP), but its relevance across treatment contexts remains uncertain. METHODS We pooled individual‐participant data from Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes (ACCORD‐MIND) and Systolic ...
Yue Qiao   +4 more
wiley   +1 more source

White matter hyperintensities are associated with locus coeruleus atrophy and astrocytic β<sub>2</sub>-adrenergic receptor expression. [PDF]

open access: yesAlzheimers Dement
Vidal V   +16 more
europepmc   +1 more source

The past, the present, and the future of preclinical mouse models for Alzheimer's disease and related dementias

open access: yesAlzheimer's &Dementia, Volume 22, Issue 8, August 2026.
Abstract Over the past decade, the Model Organism Development and Evaluation for Late‐Onset Alzheimer's Disease (MODEL‐AD) consortium has transformed preclinical Alzheimer's disease (AD) research by addressing critical limitations in traditional mouse models that failed to translate to human disease.
Adrian L. Oblak   +7 more
wiley   +1 more source

Optic Nerve Lesion Volume, White Matter Hyperintensities, and Brain Volumetrics in Multiple Sclerosis: A Multi-Sequence MRI-Based Analysis. [PDF]

open access: yesEur J Neurol
Korbecki A   +12 more
europepmc   +1 more source

Multimorbidity and Associations with Cognition and Alzheimer's Disease Biomarkers

open access: yesAnnals of Neurology, Volume 100, Issue 2, Page 370-379, August 2026.
Objective Multimorbidity, the coexistence of 2 or more chronic conditions, has been linked to cognitive aging and Alzheimer's disease (AD) and AD‐related dementias, yet the mechanisms remain unclear. We aimed to examine the associations of multimorbidity with cognition and biomarkers across multiple mechanistic pathways.
Xiaqing Jiang   +45 more
wiley   +1 more source

Cerebrospinal Fluid Amyloid‐β Biomarkers Predict Future Hemorrhage in Patients with Cerebral Amyloid Angiopathy

open access: yesAnnals of Neurology, Volume 100, Issue 2, Page 391-399, August 2026.
Objective Accurately predicting future hemorrhagic events in patients with cerebral amyloid angiopathy (CAA) remains a major clinical challenge. It is unknown whether cerebrospinal fluid (CSF) biomarkers of amyloid‐beta (Aβ) pathology are associated with increased hemorrhage risk in this population.
Philipp Arndt   +15 more
wiley   +1 more source

Diagnostic Challenges of Methanol Poisoning in Resource‐Limited Settings: A Case Series

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Methanol poisoning is a life‐threatening emergency, but diagnosis is challenging in resource‐limited settings lacking toxicology testing. This case series presents three cases of methanol poisoning: two patients with neurological symptoms and unexplained high anion gap metabolic acidosis were initially misdiagnosed as stroke or diabetic ...
Hongyun Chen   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy